COVID-19(4) SARS-CoV-2(3) activities(2) interleukin(2) clinical trial(2) UPR(2) unfolded protein response(2) Cancer(2) reducing(2) alterations(2) inhibitor(2) clinical trials(2) Symptom(2) TNF(2) metabolism(2) pandemic(2) tyrosine(2) interleukin-2(2) interleukin-2 (IL-2)(2) behavioural measures(2) indication(2) unfolded protein response (UPR).(2) Cytokine storm(2) anti-inflammatory compounds(2) Patient(2) IL-6(2) approved(2) Side effects(2) interferon(2) Area(2)